Serum oxidative markers and delta neutrophil index in hyperemesis gravidarum

Abstract

Objectives: To evaluate the relationship between different serum oxidative markers and the delta neutrophil index and hyperemesis gravidarum.

Methods: One hundred pregnant women were enrolled in the study and divided into two groups. Group 1 included 50 women with hyperemesis gravidarum, while Group 2 (control group) included 50 pregnant women similar in age, gestational week, and body mass index. Serum oxidative markers and complete blood count inflammatory markers were compared.

Results: Native thiol and total thiol were significantly lower in the Group 1 when compared with the control group (P=0.029 for native thiol; P=0.035 for total thiol). Moreover, ischemia-modified albumin (IMA) and catalase values were significantly higher in the Group 1 than in the control group (P=0.023 for IMA; P=0.021 for catalase). Index1% shows the disulfide/native thiol percent ratio and means that the Group 1 oxidant load is increased but not statistically significant. Myeloperoxidase, ferroxidase, and the delta neutrophil index did not differ significantly between the two groups (P=0.591, P=0.793, and P=0.52; respectively).

Conclusions: According to our study, contrary to the literature, although there are differences in some values, when evaluated individually hyperemesis gravidarum does not impose an extra burden on maternal oxidant-antioxidant balance.

Keywords

• Oxidative hemostasis
• hyperemesis gravidarum
• delta neutrophil index

References

1. 1. Practice Bulletin No. 153: Nausea and Vomiting of Pregnancy. Obstet Gynecol. 2015;126(3):e12-e24. doi: 10.1097/AOG.0000000000001048.
2. 2. Güney M, Oral B, Mungan T. Serum lipid peroxidation and antioxidant potential levels in hyperemesis gravidarum. Am J Perinatol. 2007;24(5):283-289. doi: 10.1055/s-2007-981429.
3. 3. Kjeldgaard HK, Eberhard-Gran M, Benth JŠ, Nordeng H, Vikanes ÅV. History of depression and risk of hyperemesis gravidarum: a population-based cohort study. Arch Womens Ment Health. 2017;20(3):397-404. doi: 10.1007/s00737-016-0713-6.
4. 4. Verberg MF, Gillott DJ, Al-Fardan N, Grudzinskas JG. Hyperemesis gravidarum, a literature review. Hum Reprod Update. 2005;11(5):527-359. doi: 10.1093/humupd/dmi021.
5. 5. Golberg D, Szilagyi A, Graves L. Hyperemesis gravidarum and Helicobacter pylori infection: a systematic review. Obstet Gynecol. 2007;110(3):695-703. doi: 10.1097/01.AOG.0000278571.93861.26.
6. 6. Aksoy H, Aksoy AN, Ozkan A, Polat H. Serum lipid profile, oxidative status, and paraoxonase 1 activity in hyperemesis gravidarum. J Clin Lab Anal. 2009;23(2):105-109. doi: 10.1002/jcla.20298.
7. 7. Fait V, Sela S, Ophir E, et al. Peripheral polymorphonuclear leukocyte priming contributes to oxidative stress in early pregnancy. J Soc Gynecol Investig. 2005;12(1):46-49. doi: 10.1016/j.jsgi.2004.08.005.
8. 8. Onaran Y, Kafali H, Duvan Cİ, Keskin E, Celik H, Erel O. Relationship between oxidant and antioxidant activity in hyperemesis gravidarum. J Matern Fetal Neonatal Med. 2014;27(8):825-828. doi: 10.3109/14767058.2013.842549.

9. 9. Agarwal A, Gupta S, Sikka S. The role of free radicals and antioxidants in reproduction. Curr Opin Obstet Gynecol. 2006;18(3):325-332. doi: 10.1097/01.gco.0000193003.58158.4e.
10. 10. Osaki S, Johnson DA, Frieden E. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J Biol Chem. 1966;241(12):2746-2751.
11. 11. Hellman NE, Gitlin JD. Ceruloplasmin metabolism and function. Annu Rev Nutr. 2002;22:439-458. doi: 10.1146/annurev.nutr.22.012502.114457.
12. 12. Agarwal A, Gupta S, Sekhon L, Shah R. Redox considerations in female reproductive function and assisted reproduction: from molecular mechanisms to health implications. Antioxid Redox Signal. 2008;10(8):1375-1403. doi: 10.1089/ars.2007.1964.
13. 13. Klebanoff SJ. Myeloperoxidase: friend and foe. J Leukoc Biol. 2005;77(5):598-625. doi: 10.1189/jlb.1204697.
14. 14. Kundi H, Ates I, Kiziltunc E, et al. A novel oxidative stress marker in acute myocardial infarction; thiol/disulphide homeostasis. Am J Emerg Med. 2015;33(11):1567-1571. doi: 10.1016/j.ajem.2015.06.016.
15. 15. Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem. 2014;47(18):326-332. doi: 10.1016/j.clinbiochem.2014.09.026.
16. 16. Papageorghiou AT, Prefumo F, Leslie K, Gaze DC, Collinson PO, Thilaganathan B. Defective endovascular trophoblast invasion in the first trimester is associated with increased maternal serum ischemia-modified albumin. Hum Reprod. 2008;23(4):803-806. doi: 10.1093/humrep/den029.
17. 17. Jauniaux E, Hempstock J, Greenwold N, Burton GJ. Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am J Pathol. 2003;162(1):115-125. doi: 10.1016/S0002-9440(10)63803-5.
18. 18. Prefumo F, Gaze DC, Papageorghiou AT, Collinson PO, Thilaganathan B. First trimester maternal serum ischaemia-modified albumin: a marker of hypoxia-ischaemia-driven early trophoblast development. Hum Reprod. 2007;22(7):2029-2032. doi: 10.1093/humrep/dem095.
19. 19. Kim H, Kim Y, Lee HK, Kim KH, Yeo CD. Comparison of the delta neutrophil index with procalcitonin and C-reactive protein in sepsis. Clin Lab. 2014;60(12):2015-2021. doi: 10.7754/clin.lab.2014.140528.
20. 20. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med. 2000;19(4):311-315. doi: 10.1016/s0736-4679(00)00255-9.
21. 21. Erel O. Automated measurement of serum ferroxidase activity. Clin Chem. 1998;44(11):2313-2319.
22. 22. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982;78(3):206-209. doi: 10.1111/1523-1747.ep12506462.
23. 23. Góth L. A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta. 1991;196(2-3):143-151. doi: 10.1016/0009-8981(91)90067-m.
24. 24. Ergin M, Cendek BD, Neselioglu S, Avsar AF, Erel O. Dynamic thiol-disulfide homeostasis in hyperemesis gravidarum. J Perinatol. 2015;35(10):788-792. doi: 10.1038/jp.2015.81.
25. 25. Ustün Y, Engin-Ustün Y, Oztürk O, Alanbay I, Yaman H. Ischemia-modified albumin as an oxidative stress marker in preeclampsia. J Matern Fetal Neonatal Med. 2011;24(3):418-421. doi: 10.3109/14767058.2010.497879.
26. 26. Rossi A, Bortolotti N, Vescovo S, et al. Ischemia-modified albumin in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2013 Oct;170(2):348-51. doi: 10.1016/j.ejogrb.2013.06.037.
27. 27. Longini M, Perrone S, Kenanidis A, et al. ESPR Abstracts: 44 Oxidative Stress in Amniotic Fluid of Pregnancies with Fetal Growth Retardation. Pediatr Res. 2004;56(3):471-471. doi: 10.1203/00006450-200409000-00067.
28. 28. Özdemir S, Kıyıcı A, Balci O, Göktepe H, Çiçekler H, Çelik Ç. Assessment of ischemia-modified albumin level in patients with recurrent pregnancy loss during the first trimester. Eur J Obstet Gynecol Reprod Biol. 2011;155(2):209-212. doi: 10.1016/j.ejogrb.2010.12.004.
29. 29. Cengiz H, Dagdeviren H, Kanawati A, et al. Ischemia-modified albumin as an oxidative stress biomarker in early pregnancy loss. J Matern Fetal Neonatal Med. 2016;29(11):1754-1757. doi: 10.3109/14767058.2015.1061494.
30. 30. Uçkan K, Demir H, Demir C. Maternal serum ischemia-modified albumin (IMA), total-sulphydryl concentrations, and some subclinic inflammatory markers in hyperemesis gravidarum (HG). Taiwan J Obstet Gynecol. 2023;62(1):101-106. doi: 10.1016/j.tjog.2022.10.006.
31. 31. Hung TH, Chen SF, Lo LM, Li MJ, Yeh YL, Hsieh TT. Myeloperoxidase in the plasma and placenta of normal pregnant women and women with pregnancies complicated by preeclampsia and intrauterine growth restriction. Placenta. 2012;33(4):294-303. doi: 10.1016/j.placenta.2012.01.004.
32. 32. Kalva-Borato DC, Ribas JT, Parabocz GC, et al. Biomarkers in Non-Complicated Pregnancy: Insights About Serum Myeloperoxidase and Ultrasensitive C-Reactive Protein. Exp Clin Endocrinol Diabetes. 2019;127(9):585-589. doi: 10.1055/a-0777-2090.
33. 33. Ege S, Bademkiran MH, Peker N, et al. Evaluation of catalase, myeloperoxidase and ferroxidase values in pregnant women with hyperemesis gravidarum. Ginekol Pol. 2019;90(11):651-655. doi: 10.5603/GP.2019.0110.
34. 34. Olivares M, Uauy R. Copper as an essential nutrient. Am J Clin Nutr. 1996;63(5):791S-796S. doi: 10.1093/ajcn/63.5.791.
35. 35. Louro MO, Cocho JA, Tutor JC. Assessment of copper status in pregnancy by means of determining the specific oxidase activity of ceruloplasmin. Clin Chim Acta. 2001;312(1-2):123-127. doi: 10.1016/s0009-8981(01)00607-6.
36. 36. Demir ME, Ulas T, Dal MS, et al. Oxidative stress parameters and ceruloplasmin levels in patients with severe preeclampsia. Clin Ter. 2013;164(2):e83-7. doi: 10.7417/CT.2013.1536.
37. 37. Nikolic A, Cabarkapa V, Novakov Mikic A, Jakovljević A, Stosic Z. Ceruloplasmin and antioxidative enzymes in pre-eclampsia. J Matern Fetal Neonatal Med. 2016;29(18):2987-2993. doi: 10.3109/14767058.2015.1111333.
38. 38. Jauniaux E, Watson AL, Hempstock J, Bao YP, Skepper JN, Burton GJ. Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am J Pathol. 2000;157(6):2111-2122. doi: 10.1016/S0002-9440(10)64849-3.
39. 39. Wu F, Tian FJ, Lin Y, Xu WM. Oxidative Stress: Placenta Function and Dysfunction. Am J Reprod Immunol. 2016;76(4):258-271. doi: 10.1111/aji.12454.
40. 40. Dal Y, Akkuş F, Karagün Ş, Çolak H, Coşkun A. Are serum delta neutrophil index and other inflammatory marker levels different in hyperemesis gravidarum? J Obstet Gynaecol Res. 2023;49(3):828-834. doi: 10.1111/jog.15542.